Home - Products - Others - Other Targets - Citreorosein

Citreorosein

CAS No. 481-73-2

Citreorosein ( )

Catalog No. M30963 CAS No. 481-73-2

Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	945	In Stock
50MG	Get Quote	In Stock
100MG	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Citreorosein
Note

Research use only, not for human use.
Brief Description

Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.
Description

Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.
Synonyms
Pathway

Others
Target

Other Targets
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

481-73-2
Formula Weight

286.2
Molecular Formula

C15H10O6
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Propargyl-PEG5-Ms

Propargyl-PEG5-Ms is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Derrone

Derrone may be interesting antimicrobial agents to be used against infectious diseases caused by many pathogens.
Valbenazine

A novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.

Sign In Join Free